Neurotrophic factors in the treatment of peripheral neuropathy

CIBA Foundation Symposia

Volumn , Issue 196, 1996, Pages 98-112

  Apfel, Stuart C ^a   Kessler, John A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NERVE PROTEIN;

ANIMAL; DIABETIC NEUROPATHY; HUMAN; NERVE COMPRESSION; PERIPHERAL NEUROPATHY; REVIEW;

ANIMALS; DIABETIC NEUROPATHIES; HUMANS; NERVE COMPRESSION SYNDROMES; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0030344754     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Aloe L, Tuveri MA, Levi-Montalcini R 1992 Studies on carrageenan-induced arthritis in adult rats: presence of nerve growth factor and role of sympathetic innervation. Rheumatol Int 12:213-216
2. Ang LC, Bhaumick B, Munoz DG, Sass J, Juurlink BH 1992 Effects of astrocytes, insulin and insulin-like growth factor I on the survival of motoneurons in vitro. J Neurol Sci 109:168-172
3. Apfel SC, Lipton RB, Arezzo JC, Kessler JA 1991 Nerve growth factor prevents toxic neuropathy in mice. Ann Neurol 29:87-89
4. Apfel SC, Arezzo JC, Lipson L, Kessler JA 1992 Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 31:76-80
5. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA 1994 Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 634:7-12
6. Apfel SC, Adornato BT, Cornblath DR et al 1995a A phase I clinical trial of nerve growth factor in patients with small fiber peripheral neuropathy. Ann Neurol, in press
7. Apfel SC, Newel M, Dormia C, Kessler JA 1995b Kappa opioid receptors participate in nerve growth factor induced hyperalgesia. Neuroscience 68:1199-1206
8. Arnand P, Rudge P, Mathias CJ et al 1991 New autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides. Lancet 337:1253-1254
9. Bennett GJ, Xie YK 1988 A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107
10. Blakeslee S 1995 Substance hailed as tool to fight neurodegenerative disease. New York Times 1/31/95 pg C3
11. Brewster WJ, Fernyhough P, Diemel LT, Mohiaddin L, Tomlinson DR 1994 Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci 17:321-325
12. Calcutt SR, Muir D, Powell HC, Mizisin AP 1992 Reduced ciliary neurotrophic factor-like activity in nerves from diabetic or galactose-fed rats. Brain Res 575:320-324
13. Contreras PC, Steffler C, Gruner JA et al 1994 Recombinant human insulin-like growth factor-1 (rhIGF-1) prevents cisplatin-induced neuropathy. Soc Neurosci Abstr 20:1096
14. Contreras PC, Steffler C, Gruner JA et al 1995 Insulin-like growth factor 1 prevents the peripheral neuropathy induced by paclitaxel, cisplatin, and vincristine. Ann Neurol 38:315-316
15. Crosby SR, Tsigos C, Anderton CD et al 1992 Elevated plasma insulin-like growth factor binding protein-1 levels in type I (insulin-dependent) diabetic patients with peripheral neuropathy. Diabetologia 35:868-872
16. Diemel LT, Brewster WJ, Fernyhough P, Tomlinson DR 1994 Expression of neuropeptides in experimental diabetes: effects of treatment with nerve growth factor for brain derived neurotrophic factor. Mol Brain Res 21:171-175
17. Faradji V, Sotelo J 1990 Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol Scand 81:402-406
18. Gao WQ, Dybdal N, Schmelzer C, et al 1994 Neurotrophin-3 reverses cisplatin-induced peripheral neuropathy. Soc Neurosci Abstr 20:442
19. Hayakawa K, Sobue G, Itoh T, Mitsuma T 1994 Nerve growth factor prevents neurotoxic effects of cisplatin, vincristine and taxol on rat sympathetic explants in vitro. Life Sci 55:519-525
20. Hellweg R, Hartung HD 1990 Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 26:258-267
21. Henderson JT, Seniuk NA, Richardson PM, Gauldie J, Roder JC 1994 Systemic administration of ciliary neurotrophic factor induces cachexia in rodents. J Clin Invest 93:2632-2638
22. Ishii DN, Lupien SB 1995 Insulin-like growth factors protect against diabetic neuropathy: effects on sensory nerve regeneration in rats. J Neurosci Res 40:138-144
23. Jakobsen J, Brimijoin S, Skau K, Sidenius P, Wells D 1981 Retrograde axonal transport of transmitter enzymes, fucose labelled protein and nerve growth factor in streptozotocin diabetic rats. Diabetes 30:797-803
24. Konings PNM, Makkink WK, van Delft AML, Ruigt GSF 1994 Reversal by NGF of cytostatic drug reduction of neurite outgrowth in dorsal root ganglia in vitro. Brain Res 640:195-204
25. Lewin GR, Ritter AM, Mendell LM 1993 Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 13:2136-2148
26. Lewis ME, Neff NT, Contreras PC et al 1993 Insulin-like growth factor-1: potential for treatment of motor neuronal disorders. Exp Neurol 124:73-88
27. Marshall JS, Stead RH, McSharry C, Nielsen L, Bienenstock J 1990 The role of mast cell degranulation products in mast cell hyperplasia. I. Mechanism of action of nerve growth factor. J Immunol 144:1886-1892
28. Miyata Y, Kashihara Y, Homma S, Kuno M 1986 Effects of nerve growth factor on the survival and synaptic function of Ia sensory neurons axotomized in neonatal rats. J Neurosci 6:2012-2018
29. Muller LJ, van der Hoop GR, Moorer van Delft CM, Gispen WH, Roubos EW 1990 Morphological and electrophysiological study of the effects of cisplatin and org2766 on rat spinal ganglion neurons. Cancer Res 50:2437-2442
30. Ordonez G, Fernandez A, Perez R, Sotelo J 1994 Low contents of nerve growth factor in serum and submaxillary gland of diabetic mice - a possible etiologic element of diabetic neuropathy. J Neurol Sci 121:163-166
31. Schaumburg HH, Berger AR, Thomas PK 1992 Anatomical classification of peripheral nervous system disorders. In: Schaumburg HH, Berger AR, Thomas PK (eds) Disorders of peripheral nerves. F.A. Davis, Philadelphia, PA, p 10-24
32. Schiff PB, Horowitz SB 1980 Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 70:1561-1566
33. Takahashi R, Yokoji H, Misawa H et al 1994 A null mutation in the human CNTF gene is not causally related to diseases. Nat Genet 7:79-84
34. Thomas D, Ren K, Dubner R 1993 Nerve growth factor alleviates a painful peripheral neuropathy in rats. Soc Neurosci Abstr 19:969
35. Van der Hoop GR, Vecht CJ, Van der Burg MEL et al 1990 Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer. N Engl J Med 322:89-94
36. Windebank AJ, Smith AG, Russell JW 1994 The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro. Neurology 44:488-494
37. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J 1994 Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 62:327-331
38. Wuarin L, Guertin DM, Ishii DN 1994 Early reduction in insulin-like growth factor gene expression in diabetic nerve. Exp Neurol 130:106-114